|
HEARTWARE, INC. HEARTWARE VENTRICULAR ASSIST SYSTEM - BATTERY; VENTRICULAR (ASSIST) BYPASS
|
Back to Search Results |
|
| Model Number |
1650DE |
| Medical Device Problem Code |
Battery Problem (2885)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
07/09/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This device is used for treatment not diagnosis.The ventricular assist system is indicated for use as a bridge to cardiac transplantation and destination therapy in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings.Concomitant medical products: 6935m62 lead, implanted: (b)(6) 2015; 5076-52 lead, implanted: (b)(6) 2015.Additional products: brand name: heartware ventricular assist system, product, including 1.0 or 2.0 for controller, brand name: model #: 1650de / catalog #: 1650de / expiration date: 31-mar-2021 / serial or lot#: (b)(4), udi #: (b)(4).Device available for evaluation? no.Device evaluated by manufacturer? no, device evaluation anticipated, but not yet begun.Device mfg date: 11-mar-2020.Labeled for single use? no.(b)(4).Brand name: heartware ventricular assist system , product, including 1.0 or 2.0 for controller, medical deivce: model #: 1650de / catalog #: 1650de / expiration date: 28-feb-2021/ serial or lot#: (b)(4), udi #: (b)(4).Device available for evaluation? no.Device evaluated by manufacturer? no, device evaluation anticipated, but not yet begun.Device mfg date: 05-feb-2020.Labeled for single use? no.(b)(4).Investigation of this event is pending and a supplemental report will be sent upon its completion.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
It was reported that the batteries were giving critical battery alarms and exhibiting communication error.The batteries remain in use.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
A supplemental report is being submitted for investigation summary.Product event summary: three (3) batteries (b)(6) were not returned for evaluation.Log file analysis revealed that the controller in use during the reported event, con312788, contained a software with a feature that records whether a power source experienced a communication error or a disconnection within each 15-minute interval.Analysis of the alarm log file revealed twelve (12) critical battery alarms due to a communication errors involving (b)(6) logged since on (b)(6) 2020.Additionally, analysis of the data log file revealed several instances involving (b)(6) where the battery relative state of charge (rsoc) was between 101-201, which is indicative of communication errors.As a result, the reported event was confirmed.There is no evidence that the lubrication servicing was performed on (b)(6).The batteries (b)(6) had been lubricated prior to release.The most likely root cause of the reported event can be attributed to a communication error between the controller and batteries, which may be due to a momentary disconnection on the communication pins of the controller, the controller not receiving responses from the batteries, and / or due to the packet error checking method detecting bit errors.Additional products: d1: heartware ventricular assist system ¿battery serial or lot#: (b)(6); h6:device code(s): 2885 h6: fda results code(s): 3213 h6: fda conclusion code(s): 4307 d1: heartware ventricular assist system ¿battery; serial or lot#: (b)(6); h6:device code(s): 2885 h6: device code(s): c63030 h6: fda results code(s): 3213 h6: fda conclusion code(s): 4307; investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Search Alerts/Recalls
|
|
|